Summary
GLAXOSMITHKLINE'S potentially revolutionary inoculation against cervical cancer will take top billing as the drugs giant updates the market on its bulging pipeline of new vaccines later today.
The treatment, called Cervarix, is only one of a number of promising new pills and jabs under development.See the full content of this document
Extract
Blockbuster Hopes for Gsk
Jean Stephenne, head of GSK's biol...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
thrive the age of the freelancer? | Moishe's Bagel Rip-Roaring[...] | Pepe Can Rein with Us Pepecan Rein Here Dalglish Pepecan Rein Here Dalglish | true gris ; put spring's pretty pastels on hold and play it cool from eyes to ... | how to understand politics. | fitch u.s subprime rmbs rating action recap aug 13 2007. | Company Watch Swiss International. | FINEOS Announces New Board Appointment to Support Global Expansion.
